Overview
- Federal disclosures show President Trump purchased between $1 million and $5 million of Axon stock on Feb. 10, weeks before ICE posted a notice seeking up to $220 million for energy weapons on Feb. 24.
- Procurement reviewers and policing experts say the ICE notice's technical requirements, such as a 45‑foot effective range and 10 deployable probes, track closely with Axon’s TASER 10 and would be hard for rivals to meet.
- Axon’s shares jumped sharply after the solicitation, rising more than 34 percent in the seven days after the notice and producing material paper gains for anyone who held stock through that period.
- The White House says the president’s assets sit in a trust managed by his children and investments are handled by independent firms and it denies any conflicts; reporting finds no public evidence that Trump influenced the procurement.
- Ethics watchdogs warn the sequence raises appearance‑of‑conflict concerns that can erode public trust and could increase scrutiny of the pending award and of Axon’s dominant position in the U.S. Taser market.